Rani Therapeutics Holdings (RANI) Debt Ratio (2020 - 2025)

Rani Therapeutics Holdings has reported Debt Ratio for 6 years, with the latest figure at 1.34 in Q3 2025.

• On a quarterly basis, Debt Ratio rose 105.38% year-over-year to 1.34 in Q3 2025; TTM through Sep 2025 was 1.34, a 105.38% increase from a year earlier, with the FY2024 full-year figure at 0.67, up 32.44% from the prior year.
• Debt Ratio was 1.34 for Q3 2025 at Rani Therapeutics Holdings, up from 1.02 in the prior quarter.
• The five-year high for Debt Ratio was 1.34 in Q3 2025, with the low at 0.0 in Q2 2022.
• Average Debt Ratio over 5 years is 0.43, with a median of 0.38 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Debt Ratio slumped 99.53% in 2022, then soared 121791.07% in 2023.
• Over 5 years, Debt Ratio stood at 0.0 in 2021, then soared by 26547.46% to 0.27 in 2022, then jumped by 87.67% to 0.51 in 2023, then soared by 32.44% to 0.67 in 2024, then jumped by 98.72% to 1.34 in 2025.
• The last three Debt Ratio figures came in at 1.34 (Q3 2025), 1.02 (Q2 2025), and 0.87 (Q1 2025), per Business Quant data.